StockNews.com upgraded shares of Ocular Therapeutix (NASDAQ:OCUL – Get Rating) from a sell rating to a hold rating in a research note released on Wednesday morning. OCUL has been the topic of a number of other reports. JMP Securities raised their price target on Ocular Therapeutix from $11.00 to $12.00 in a research note on […]
StockNews.com upgraded shares of Ocular Therapeutix (NASDAQ:OCUL – Get Rating) from a sell rating to a hold rating in a research note published on Wednesday morning. Several other equities research analysts have also weighed in on the company. JMP Securities lifted their price objective on Ocular Therapeutix from $11.00 to $12.00 in a report on […]
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Rating) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 6,650,000 shares, a growth of 20.3% from the May 15th total of 5,530,000 shares. Based on an average trading volume of 977,800 shares, the […]
Ocular Therapeutix (NASDAQ:OCUL – Get Rating) had its target price boosted by HC Wainwright from $10.00 to $12.00 in a research note published on Tuesday, The Fly reports. A number of other research firms have also recently commented on OCUL. JMP Securities lifted their price objective on Ocular Therapeutix from $11.00 to $12.00 in a […]
Ocular Therapeutix (NASDAQ:OCUL – Get Rating) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday. A number of other research analysts have also recently weighed in on the company. Robert W. Baird lifted their price objective on Ocular Therapeutix from $10.00 […]